Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

Idelalisib — mesenchymal druggability

MeasuredDerived

Inhibition of Idelalisib across the 47 mesenchymal-specific kinases of Table S9 (1 µM single dose). Weighted inhibition 2.7% · mean inhibition 2.7% · 0/47 kinases inhibited to ≤ 35% residual activity.

Strongest inhibition shown left. Inhibition % = 100 − residual activity %.

Per-kinase profile

Kinase (RBC label)HGNCResidual %Inhibition %Mes/epi fold-changeStatus
DRAK1_STK17ASTK17A83.416.61.98Upregulated
BMPR2BMPR284.415.61.10Upregulated
PDGFRBPDGFRB89.410.63.93Upregulated
FYNFYN91.68.41.85Upregulated
DCAMKL2DCLK291.78.31.52Upregulated
FGFR1FGFR193.26.82.73Upregulated
EGFREGFR93.36.71.50Upregulated
CAMK4CAMK493.36.71.06Upregulated
ABL2_ARGABL294.06.01.66Upregulated
MEKK3MAP3K394.65.41.03Upregulated
CAMK1ACAMK194.65.41.86Upregulated
PKCAPRKCA96.04.02.09Upregulated
LIMK1LIMK196.53.51.10Upregulated
PLK2PLK296.63.42.42Upregulated
EPHA2EPHA296.63.41.22Upregulated
AKT3AKT397.32.72.59Upregulated
TIE2_TEKTEK98.02.01.16Upregulated
ALK2_ACVR1ACVR198.02.01.66Upregulated
CAMK2DCAMK2D98.21.81.19Upregulated
ALK5_TGFBR1TGFBR198.61.41.12Upregulated
HGK_MAP4K4MAP4K498.71.31.66Upregulated
SGK1SGK198.81.22.88Upregulated
PKCMU_PRKD1PRKD198.91.12.02Upregulated
EPHA5EPHA599.60.41.50Upregulated
AXLAXL99.60.45.65Upregulated
CDK15_CYCLIN_A2CDK1599.90.12.05Upregulated
JAK1JAK1100.00.01.17Upregulated
NEK6NEK6100.00.01.67Upregulated
NEK7NEK7100.00.01.54Upregulated
PDGFRAPDGFRA100.00.02.74Upregulated
MLCK_MYLKMYLK100.00.04.25Upregulated
C_METMET100.00.01.20Upregulated
HIPK2HIPK2100.00.01.12Upregulated
PKCNU_PRKD3PRKD3100.00.01.04Upregulated
EPHB2EPHB2100.00.01.15Upregulated
RSK3RPS6KA2100.00.01.66Upregulated
EPHA4EPHA4100.00.01.10Upregulated
TGFBR2TGFBR2100.00.02.39Upregulated
DYRK3DYRK3100.00.01.57Upregulated
ZIPK_DAPK3DAPK3100.00.01.16Upregulated
DDR2DDR2100.00.03.68Upregulated
ARK5_NUAK1NUAK1100.00.01.97Upregulated
DLK_MAP3K12MAP3K12100.00.01.29Upregulated
LATS2LATS2100.00.01.37Upregulated
PEAK1PEAK1100.00.01.59Upregulated
PKACBPRKACB100.00.01.25Upregulated
STK32B_YANK2STK32B100.00.01.72Upregulated

← All inhibitors